Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Matcha (Camellia sinensis) is a shade-grown green tea powder containing exceptionally high concentrations of EGCG and L-theanine due to consuming the entire leaf. The shade cultivation process increases amino acid content by up to 45% while concentrating catechins that inhibit NF-κB and PI3K/Akt pathways for antioxidant and anti-inflammatory effects.
Reported Benefits (Provisional)
Origin & History
Matcha is a finely milled powder derived from shade-grown green tea leaves (Camellia sinensis), traditionally cultivated in Japan, particularly in regions like Uji and Nishio. Unlike regular green tea, consuming the entire leaf offers a concentrated source of nutrients. The unique shading process increases chlorophyll and L-theanine levels, enhancing its therapeutic and cognitive benefits.
Research Narrative (Provisional)
Supported by numerous studies on EGCG and green tea extract, matcha has been shown to improve metabolic rate, enhance cognitive function, and support cardiovascular health. The synergy between L-theanine and caffeine is particularly well-studied for promoting calm focus and reducing stress markers.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Phytochemicals: Epigallocatechin gallate (EGCG), Catechins, Polyphenols, Flavonoids (potent antioxidants) - Amino Acids: L-theanine (promotes relaxation and focus) - Stimulants: Caffeine - Pigments: Chlorophyll (detoxification support) - Vitamins: Vitamin A, Vitamin C, Vitamin E, B-complex (Thiamine, Riboflavin) - Minerals: Potassium, Magnesium, Calcium, Selenium, Chromium, Zinc - Fiber: Dietary fiber
Reported Mechanism (Provisional)
Matcha's primary catechin EGCG blocks inflammatory NF-κB, MAPK, and TLR4-NF-κB pathways while reducing cytokines like TNF-α, IL-1β, and IL-6. The synergistic combination of L-theanine and caffeine modulates neurotransmitter activity for sustained alertness without jitters. Antioxidant activity reaches 1815 µM TEAC/g dry matter through phenolic compounds that neutralize ROS and inhibit PI3K/Akt signaling pathways.
Clinical Narrative (Provisional)
Current evidence for matcha is primarily based on in vitro and preclinical studies rather than human clinical trials with specific numerical outcomes. Antioxidant studies show quantified ABTS radical scavenging capacity of 1533-1815 µM TEAC/g dry matter and total phenolics of 820-1018 mg GAE/L in extracts. While numerous studies support green tea extract benefits, dedicated matcha clinical trials with patient endpoints, sample sizes, and statistical outcomes are lacking. The evidence strength remains moderate, relying heavily on extrapolation from broader Camellia sinensis research.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.